mr muhammad abdul rehman
Trade trend analysis
Number of Transactions Quantity Weight
Number of Transactions Quantity Weight
The above chart presents the market trend analysis for mr muhammad abdul rehman from 2025 to 2026. By examining various dimensions such as transaction quantity, transaction weight, average price, and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability. As of 2026, the company has completed 2 transactions, with a transaction quantity of 24 and a transaction weight of 0.
- Year Transactions Quantity Weight
- 2025 1 12 0
- 2026 2 24 0
Bill of lading data
< 1/3 >- Trade date 2026/06/16 B/L No. ——
- Suppliers clinigen healthcare ltd. Buyers mr muhammad abdul rehman
- POLs —— PODs kpfi
- Supply area England Purchas area Pakistan
- Weight —— Amount 431.344356
- Hs code 30049099 Product tags adce,cancer,pro,brentuximab,delivery,medicine,health,amine,release,edot,dy e
- Product description ALREADY EAXAMINED AND RELEASED DELIVERY (MEDICINE FOR CANCER PATIENT)HEALTH ACCESS PROGRAM 1002866 ADCETRIS — BRENTUXIMAB VEDOTIN— 50 MG Expand
- Trade date 2026/03/06 B/L No. ——
- Suppliers clinigen healthcare ltd. Buyers mr muhammad abdul rehman
- POLs —— PODs kpfi
- Supply area England Purchas area Pakistan
- Weight —— Amount 429.645542
- Hs code 30049099 Product tags adce,cancer,pro,brentuximab,delivery,medicine,health,amine,release,edot,dy e
- Product description ALREADY EXAMINED AND RELEASED DELIVERY (MEDICINE FOR CANCER PATIENT)HEALTH ACCESS PROGRAM 1002866/ ADCETRIS - BRENTUXIMAB VEDOTIN 50 MG Expand
- Trade date 2025/11/04 B/L No. ——
- Suppliers clinigen healthcare td Buyers mr muhammad abdul rehman
- POLs —— PODs kpfi
- Supply area England Purchas area Pakistan
- Weight —— Amount 427.35
- Hs code 30049099 Product tags adce,cancer,pro,brentuximab,delivery,medicine,health,amine,release,edot,dy e
- Product description ALREADY EXAMINED AND RELEASED DELIVERY (MEDICINE FOR CANCER PATIENT) HEALTH ACCESS PROGRAM 1002866/ ADCETRIS-BRENTUXIMAB VEDOTIN- 50 MG Expand
Partners
Total 2- Rank Company Transactions Per Detail
- 1 clinigen healthcare ltd. englandbuyer,they trade on 2026-06-16 2 66.67% >
- 2 clinigen healthcare td englandsupplier,they trade on 2025-11-04 1 33.33% >
Products
Total 11- Products Transactions Per Detail
-
adce
1 100% > -
amine
1 100% > -
brentuximab
1 100% > -
cancer
1 100% > -
delivery
1 100% >
+View All
Hscode rank
Total 0- HSCode Name Transactions Per Detail
- HS 30049099 1 100% >
Trading Area
Total 1- Area Transactions Per Detail
- england 3 100.00% >
Port statistics
Total 1- Port Name Transactions Per Detail
- kpfi 3 100.00% >